scholarly article | Q13442814 |
P2093 | author name string | Snider GL | |
O'Brien JJ | |||
Goldstein RH | |||
Celli BR | |||
Lucey EC | |||
P433 | issue | 2 | |
P921 | main subject | carbon monoxide | Q2025 |
pulmonary fibrosis | Q32446 | ||
P304 | page(s) | 289-297 | |
P577 | publication date | 1978-02-01 | |
P1433 | published in | The American Review of Respiratory Disease | Q26839505 |
P1476 | title | Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied | |
P478 | volume | 117 |
Q37664164 | A mouse model of chronic idiopathic pulmonary fibrosis |
Q53763737 | Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9. |
Q35819150 | Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence |
Q41751872 | Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation |
Q33840511 | Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells |
Q39525128 | Bleomycin-induced lung injury in baboons: Alteration of cells and immunoglobulins recoverable by bronchoalveolar lavage |
Q39541916 | Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin |
Q41967080 | Bleomycin-stimulated hamster alveolar macrophages release interleukin-1. |
Q35836499 | Capillary remodeling in bleomycin-induced pulmonary fibrosis |
Q41908752 | Changes in distribution, morphology, and tumor necrosis factor-alpha secretion of alveolar macrophage subpopulations during the development of bleomycin-induced pulmonary fibrosis |
Q72715663 | Chronic airway obstruction and bronchiectasis in the rat after intratracheal bleomycin |
Q41127857 | Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats |
Q35070654 | Direct leukocyte migration across pulmonary arterioles and venules into the perivascular interstitium of murine lungs during bleomycin injury and repair |
Q46726026 | Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury. |
Q36287478 | Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice |
Q30705373 | Effects of a calmodulin inhibitor on bleomycin-induced lung inflammation in hamsters. Biochemical, morphometric, and bronchoalveolar lavage data |
Q36227450 | Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis |
Q50351279 | Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice. |
Q45047357 | Lung lymphocytes in bleomycin-induced pulmonary disease |
Q37543830 | Lung parenchymal mechanics in health and disease |
Q36356735 | Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation |
Q38610456 | Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades |
Q49603082 | Modeling Idiopathic Pulmonary Fibrosis in Humanized SCID Mice. |
Q35858455 | Modulation of bleomycin-induced pulmonary fibrosis in the BALB/c mouse by cyclophosphamide-sensitive T cells |
Q35885653 | Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. |
Q46210414 | Prevention of bleomycin-induced fibrosing alveolitis with indomethacin: Stereological studies on rat lungs |
Q34563633 | Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis |
Q35034650 | Pulmonary function testing in small laboratory mammals |
Q34183326 | Radiation effects in the lung |
Q35533319 | Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters |
Q67531268 | Superoxide anion production by rat neutrophils at various stages of bleomycin-induced lung injury |
Q37346515 | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance |
Q36970923 | The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? |
Q40103779 | The correlation of lung structure with function |
Q42735294 | The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats |
Q35885084 | The effect of alpha-difluoromethylornithine on the development of bleomycin-induced pulmonary fibrosis in hamsters. |
Q41837635 | The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis. |
Q41891748 | The role of soluble factors in bleomycin-induced pulmonary fibrosis |
Q34186283 | Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis |
Q44181987 | Time course of bleomycin-induced lung fibrosis. |
Q46573924 | gamma-Linolenic acid-containing diet attenuates bleomycin-induced lung fibrosis in hamsters |
Q42734045 | β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix |
Search more.